M. D. Anderson Cancer Center - News Releases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Cell maturity pathway is deleted or weak in glioblastoma multiforme
A program that pushes immature cells to grow up and fulfill their destiny as useful, dedicated cells is short-circuited in the most common and deadly form of brain tumor, scientists at The University of Texas MD Anderson Cancer Center report this week in the Early Edition of the Proceedings of the National Academy of Sciences (PNAS). (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 9, 2013 Category: Cancer & Oncology Source Type: news

Game on: Tobacco-Free Teens app goes live on iTunes
An app to prevent teens from smoking and encourage them to quit if they've started is now just a few taps away and available free on the Apple iTunes Store. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 9, 2013 Category: Cancer & Oncology Source Type: news

Couple pledges $10 million gift to head and neck cancer research, treatment
Charles and Daneen Stiefel, of Raleigh, N.C., have pledged $10 million to the Head and Neck Cancer Center at The University of Texas MD Anderson Cancer Center. In honor of their generosity, the institution will name the Charles and Daneen Stiefel Center for Head and Neck Cancer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 9, 2013 Category: Cancer & Oncology Source Type: news

Targeted therapy identified for protein that protects and nourishes cancer
Skp2 inhibitor discovered that blocks malignancy-promoting effects, stymies cancer stem cells and shrinks tumors in preclinical studies (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 1, 2013 Category: Cancer & Oncology Source Type: news

Company launched by MD Anderson to be acquired by Abbott
A private company based on technology discovered at The University of Texas MD Anderson agreed last week to be purchased by Abbott Laboratories, Inc., for $310 million. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 25, 2013 Category: Cancer & Oncology Source Type: news

From Prevention to Survivorship: The Obesity-Cancer Challenge
MD Anderson Backgrounder 07/19/13 With growing understanding of the links between obesity and cancer,  MD Anderson Cancer Center is applying knowledge across the continuum of care.    (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 24, 2013 Category: Cancer & Oncology Source Type: news

UT MD Anderson repeats as nation's top hospital for cancer in annual survey
According to the U.S. News & World Report's annual "Best Hospitals" survey, The University of Texas MD Anderson Cancer Center is the nation's top hospital for cancer care, a ranking it has held for seven straight years. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 16, 2013 Category: Cancer & Oncology Source Type: news

Researchers pinpoint sources of fibrosis-promoting cells that ravage organs
Scientists have tracked down and quantified the diverse origins of cells that drive fibrosis, the incurable, runaway wound-healing that scars and ultimately destroys organs such as the lungs, liver and kidneys. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 3, 2013 Category: Cancer & Oncology Source Type: news

Making Cancer History® Seminar returns to Aspen Meadows Resort
The University of Texas MD Anderson Cancer Center plans its 15th annual Making Cancer History® Seminar in Aspen, 1-3 p.m. July 16. The free event is at Aspen Meadows Resort's Paepcke Auditorium, 1000 N. Third St. Seating is limited. See registration information below. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 27, 2013 Category: Cancer & Oncology Source Type: news

'Emperor of All Maladies' Author Headlines Cancer Survivorship Conference Sept. 27-28
Cancer researcher and oncologist Siddhartha Mukherjee, M.D., Ph.D., is fascinated with the human struggle to understand and control the devastating power of cancer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 27, 2013 Category: Cancer & Oncology Source Type: news

Cooper University Health Care and MD Anderson Cancer Center Announce Partnership
Cooper University Health Care and MD Anderson Cancer Center have signed a letter of intent to form a partnership that will provide cancer patients in the region with access to the most advanced cancer treatments available. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 24, 2013 Category: Cancer & Oncology Source Type: news

Children's Cancer Hospital Opens New Combination Inpatient and Outpatient Unit
New and unique space consolidates pediatric treatment services on one floor with patient amenities (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 24, 2013 Category: Cancer & Oncology Source Type: news

Ibrutinib continues strong showing against mantle cell lymphoma
In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL). (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 20, 2013 Category: Cancer & Oncology Source Type: news

Scientists catch EGFR passing a crucial message to cancer-promoting protein
Researchers have discovered and mapped the signaling network between two previously unconnected proteins, exposing a link that, if broken, could cut off cancer cell growth at its starting point. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 19, 2013 Category: Cancer & Oncology Source Type: news

Study finds glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life
Many glioblastoma patients treated with bevacizumab (Avastin®) have significant deterioration in neurocognitive function, symptoms and quality of life. Not only that, the changes often predict treatment outcomes, according to new research from The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 4, 2013 Category: Cancer & Oncology Source Type: news